Merit Medical Systems (MMSI) Research & Development (2010 - 2026)

Merit Medical Systems has disclosed Research & Development across 17 years of filings, most recently posting $25.4 million for Q2 2026.

• In Q2 2026, Research & Development rose 4.19% year-over-year to $25.4 million; the TTM figure through Jun 2026 stood at $98.5 million (up 6.42% YoY), while the FY2025 annual figure was $97.4 million, up 11.3% from the prior year.
• Research & Development came in at $25.4 million for Q2 2026 at Merit Medical Systems, up from $22.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $26.5 million in Q4 2025 to a low of $17.4 million in Q1 2022.
• Average Research & Development over 5 years is $21.7 million, with a median of $21.4 million recorded in 2023.
• Year-over-year, Research & Development advanced 0.15% in 2022 and grew 22.59% in 2023.
• Over 5 years, Research & Development stood at $20.4 million in 2022, then grew by 5.89% to $21.6 million in 2023, then advanced by 16.43% to $25.2 million in 2024, then grew by 5.35% to $26.5 million in 2025, then slipped by 4.34% to $25.4 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $25.4 million in Q2 2026, $22.6 million in Q1 2026, and $26.5 million in Q4 2025.